New Items

Approx. Rs 3,200 / PieceGet Latest Price

Product Details:

Here’s a professional product description you can use for IndiaMART or your catalog: ⸻ Canidula Injection – Product Description Canidula Injection contains Anidulafungin, a potent antifungal medication used for the treatment of serious fungal infections, especially in hospitalized or immunocompromised patients. It belongs to the echinocandin class of antifungals and is highly effective against Candida species. ⸻ 🔹 Key Features • Broad-spectrum antifungal injection • Effective against Candida infections • Suitable for critical care use • Administered via IV infusion • High efficacy with targeted action ⸻ 🔹 Composition • Anidulafungin – 100 mg per vial • Lyophilized powder for reconstitution ⸻ 🔹 Indications • Candidemia (bloodstream fungal infection) • Invasive candidiasis • Esophageal candidiasis ⸻ 🔹 Mechanism of Action Anidulafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, leading to cell wall damage and fungal cell death. ⸻ 🔹 Dosage & Administration • Given as intravenous (IV) infusion only • Loading dose followed by maintenance dose • Administered under strict medical supervision ⸻ 🔹 Storage • Store below 25°C • Protect from light • Keep in original packaging ⸻ 🔹 Safety Information • May cause mild infusion reactions, nausea, or headache • Use with caution in liver impairment • For hospital use only ⸻ 🔹 Packaging • Single vial (lyophilized powder)

Approx. Rs 8,000 / PieceGet Latest Price

Product Details:

Omalirel Injection contains Omalizumab, a monoclonal antibody used for the treatment of allergic asthma and chronic idiopathic urticaria (chronic hives). It works by targeting IgE antibodies and reducing allergic responses in the body. ⸻ 🔹 Key Features • Advanced anti-IgE therapy • Reduces frequency and severity of allergic reactions • Effective in severe persistent allergic asthma • Long-term control of chronic urticaria (hives) ⸻ 🔹 Composition • Omalizumab – 150 mg / 300 mg per vial (as per variant) ⸻ 🔹 Indications • Moderate to severe allergic asthma (not controlled by inhalers) • Chronic spontaneous urticaria (hives not responding to antihistamines) ⸻ 🔹 Mechanism of Action Omalizumab binds to Immunoglobulin E (IgE), preventing it from attaching to receptors on mast cells and basophils. This reduces the release of inflammatory chemicals responsible for allergic symptoms. ⸻ 🔹 Dosage & Administration • Administered as subcutaneous (SC) injection • Dose depends on body weight and IgE levels • Given every 2–4 weeks under medical supervision ⸻ 🔹 Storage • Store at 2°C to 8°C (Refrigerated) • Do not freeze • Protect from light